JD HEALTH(JDHIY)
Search documents
京东健康(06618.HK)拟3月5日举行董事会会议审批年度业绩
Ge Long Hui A P P· 2026-02-20 11:48
格隆汇2月20日丨京东健康(06618.HK)宣布,公司将于2026年3月5日(星期四)举行董事会会议,以(其中 包括)批准公司及其子公司截至2025年12月31日止年度之年度业绩及其发布,以及考虑建议派付末期股 息(如有)。 ...
京东健康(06618) - 董事会会议日期

2026-02-20 10:10
香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責,對其準確性或完整性亦不發表 任何聲明,並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 JD Health International Inc. 京東健康股份有限公司 (於開曼群島註冊成立的有限公司) (股份代號:6618(港幣櫃台)及86618(人民幣櫃台)) 董事會會議日期 京东健康股份有限公司(「本公司」)董事(「董事」)會(「董事會」)謹此宣佈,本公司將於 2026年3月5日(星期四)舉行董事會會議,以(其中包括)批准本公司及其子公司截至2025 年12月31日止年度之年度業績及其發佈,以及考慮建議派付末期股息(如有)。 本公司管理層將於2026年3月5日(星期四)下午五時正(北京╱香港時間)舉行電話會議, 以討論本公司及其子公司截至2025年12月31日止年度的財務業績。 普通話頻道參會者密碼:187150 英文頻道參會者密碼: 611787 更多國家及地區撥入號碼,請點擊此處: https://smart.quanshi.com/initAccessNumberPageActio ...
新年暖相伴 送礼送健康 京东健康以营养健康礼为老用户送祝福
Sou Hu Wang· 2026-02-11 08:55
Core Insights - JD Health has launched a special user appreciation campaign for the Spring Festival, collaborating with various health brands to offer customized health gift packages to loyal users [1][3] Group 1: User Engagement and Loyalty - The campaign targets loyal users who have been purchasing from JD Health for six years, with a consistent monthly order for 72 months, showcasing diverse consumer profiles [3] - The ongoing orders reflect a narrative of care and lifestyle, driving JD Health to continuously optimize its products and services [3] Group 2: Market Trends and Consumer Behavior - During the New Year shopping festival, JD Health reported a 13-fold increase in daily visitor traffic for health gift products, with a 3.5-fold increase in searches for "New Year gift boxes" [3] - Searches for specific categories like fish oil, bird's nest, and protein powder doubled, indicating a shift towards more professional and precise gift choices among consumers [3] Group 3: Professional Services and Support - Along with the health products, users receive a year-long free one-on-one service from professional nutritionists, available for online consultations regarding nutritional products and dietary advice [5] - The nutritionist team will be available during the Spring Festival to provide tailored dietary suggestions for various demographics, including those with specific health concerns [5] Group 4: Strategic Direction - JD Health is integrating emotional connection with professional services, evolving health care from one-time gifts to long-term support, establishing itself as a reliable choice for health management during festive seasons [7]
京东健康携手CAFF花园发起“闲置变年货”公益行动 云南困境家庭孩子收到新春礼物
Sou Hu Wang· 2026-02-09 08:04
Core Viewpoint - The "New Year Garden Party" organized by JD Health and CAFF in Yunnan provided over fifty children from disadvantaged families with gifts, emphasizing community support and engagement through the "Idle Becomes New Year Goods" initiative [1][3][5]. Group 1: Event Overview - The event allowed children to earn points through participation in various activities, which they could exchange for gifts, creating a sense of achievement and joy [3]. - Gifts included AI toys, lamps, clocks, and educational materials, donated by JD Health and its partners, ensuring a blend of fun and practicality [3][5]. Group 2: Community Engagement - The "Idle Becomes New Year Goods" initiative called for donations of unused items from the public, with JD Logistics providing discounted shipping and collection services [5]. - The CAFF project team ensured that all donated items were carefully reviewed and repackaged to guarantee that each gift was filled with love [5]. Group 3: Ongoing Support and Future Plans - Starting in 2023, JD Health will continue to support families of individuals with mental disabilities, including donating laptops to university students from these families for three consecutive years [7]. - The CAFF project has gained national attention, with a new initiative set to launch in 2025, supported by the Chinese government, highlighting the increasing focus on mental health issues [7].
京东健康(06618):CSIWM 个股点评:强劲的销售增长:京东健康
citic securities· 2026-02-06 07:04
本文是由投资/产品专员而非分析师撰写的文章汇编。 它不构成研究报告,也不应被解释为研究报告,也不旨在提供 专业、投资或任何其他类型的建议或推荐。 CSIWM 个股点评 2026 年 2 月 6 日 京东健康 6618 HK 本文内容由 Kylie Kwok (郭凯欣) 提供 中信证券财富管理(香港) 产品及投资方案部 中国互联网行业 电话:(852) 2237 9250 / 电邮:wminvestmentsolutions@citics.com.hk 强劲的销售增长 摘要 中信证券财富管理与中信里昂研究观点一致。根据中信里昂研究 2026 年 2 月 3 日发布的题为《Robust sales growth》的报告,分析预计京东健康(JDH)将在 2025 年下半年保持强劲增长势头,收入将同比增长,主要是因 为"双 11"表现强劲,以及 12 月流感病例激增所导致。药品与保健品销售表现尤为突出,经调整息税前利润预计翻 倍,主要得益于毛利率扩张和运营杠杆效应,抵消了线下门店投资。分析指出,预计京东健康在 2026 年收入实现同 比增长但且上行风险显著,因为原研药和院内药品外流是长年趋势。 分析预计京东健康在 2 ...
京东健康(06618) - 截至二零二六年一月三十一日止月份之股份发行人的证券变动月报表

2026-02-05 08:31
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致:香港交易及結算所有限公司 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06618 | | 說明 | | | | | | | | | 多櫃檯證券代號 | 86618 | RMB | 說明 | | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | | 100,000,000,000 | USD | | 0.0000005 | USD | | 50,000 | | 增加 / 減少 (-) | | | | 0 | | | | USD | | 0 | | 本月底結存 | | | | 100,000,000,000 | USD | | ...
伊利妍漾联名定制燕窝粥新品在京东健康独家首发
Sou Hu Wang· 2026-02-05 07:39
Group 1 - JD Health and Yili Group have launched a co-branded product, a milk oat bird's nest porridge, aimed at high-end health needs for consumers [1][3] - The new product combines high-quality milk, premium oats, and traceable bird's nest, catering to nutrition, taste, and convenience, making it a unique choice in the New Year gift market [1][3] - The collaboration reflects the ability of both companies to develop customized products based on specific consumer scenarios and trends [3] Group 2 - During the New Year shopping season, there is a notable trend of "sending health as gifts," with significant increases in searches for health gift boxes and related products [3] - From January 26 to February 1, the average daily visitor volume for health gift box products increased 13 times year-on-year, while searches for New Year gift boxes rose 3.5 times [3] - The rising interest in traditional health products like bird's nest has doubled in search volume, indicating strong consumer demand for high-quality health products before the Spring Festival [3]
里昂:续予京东健康“跑赢大市”评级 目标价71港元
Zhi Tong Cai Jing· 2026-02-04 06:40
Core Viewpoint - Credit Lyonnais has raised JD Health's (06618) adjusted net profit forecasts for the fiscal years 2026 and 2027 by 1% and 2% respectively, reflecting the recovery in drug sales and profit expansion prospects, while maintaining an "Outperform" rating and a target price of HKD 71 [1] Group 1: Financial Performance - JD Health is expected to maintain growth momentum in the second half of last year, driven by strong performance during the Double Eleven sales event and a surge in flu cases in December, with revenue projected to increase by 24.5% year-on-year to RMB 37.1 billion [1] - The company is anticipated to see adjusted EBIT double year-on-year to RMB 2.1 billion, supported by gross margin expansion and operational leverage [1] - Revenue for 2026 is expected to grow by 16% year-on-year [1]
里昂:续予京东健康(06618)“跑赢大市”评级 目标价71港元
智通财经网· 2026-02-04 06:40
京东健康受双十一销售表现良好及12月流感感染个案激增所推动,预计去年下半年可保持增长势头,收 入同比升24.5%至371亿元人民币。该行续预期,受毛利率扩张与营运杠杆支撑,经调整EBIT或同比翻 倍至21亿元人民币,并预计公司2026年收入将同比增长16%。 智通财经APP获悉,里昂发布研报称,上调京东健康(06618)2026及2027财年经调整净利润预测1%及 2%,以反映药物销售复苏及利润扩张前景,重申"跑赢大市"评级,续予目标价71港元。 ...
大行评级丨里昂:重申京东健康“跑赢大市”评级,上调今明两年盈测
Ge Long Hui· 2026-02-04 03:29
Core Viewpoint - The report from Citi indicates that JD Health is expected to maintain growth momentum in the second half of last year, driven by strong performance during the Double Eleven sales event and a surge in flu cases in December [1] Financial Performance - Revenue is projected to increase by 24.5% year-on-year to 37.1 billion yuan [1] - Adjusted EBIT is expected to double year-on-year to 2.1 billion yuan, supported by margin expansion and operational leverage [1] Profit Forecast - Citi has raised JD Health's adjusted net profit forecasts for the fiscal years 2026 and 2027 by 1% and 2% respectively, reflecting the recovery in drug sales and profit expansion prospects [1] - The firm maintains a "Outperform" rating and sets a target price of 71 HKD for JD Health [1]